Higher doses of upadacitinib show added benefits for adults with moderate-to-severe AD when compared to dupilumab, according to a new study.

Many patients with bullous dermatoses experience depression, and the degree of that depression appears to be related to the severity of...

Individuals with skin diseases including atopic dermatitis (AD), psoriasis, vitiligo and chronic urticaria (CU) are not at elevated risk...

According to a new study, adults with AD have a higher incidence of systemic, autoimmune, and psychiatric comorbidities than those without.

Systemic sclerosis (SSC) may be more common in Black children than previously thought, according to new findings. This discrepancy may be...

Patients being treated with dupilumab for atopic dermatitis may experience less severe Covid-19 symptoms, according to a new study.

An online survey of nearly 41,000 people in the U.S. has concluded that the prevalence of vitiligo may be much higher than reported. The...

New findings suggest that dendritic cells behave differently in the skin than elsewhere in the body, in contrast to the established...